These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38248366)

  • 1. Assessing Botulinum Toxin Effectiveness and Quality of Life in Axillary Hyperhidrosis: A One-Year Prospective Study.
    Castiglione L; Murariu M; Boeriu E; Enatescu I
    Diseases; 2024 Jan; 12(1):. PubMed ID: 38248366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Assessment of Facial Hyperhidrosis Management: Evaluating the Utility and Quality of Life Improvements following Botulinum Toxin Injection.
    Prodan-Barbulescu C; Castiglione L; Burtic SR; Murariu M; Reddy S; Rosca O; Bratosin F; Melania Fizedean C; Krupyshev P; Enatescu I
    Toxins (Basel); 2024 Jan; 16(1):. PubMed ID: 38276535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin Versus Placebo: A Meta-Analysis of Treatment and Quality-of-life Outcomes for Hyperhidrosis.
    Obed D; Salim M; Bingoel AS; Hofmann TR; Vogt PM; Krezdorn N
    Aesthetic Plast Surg; 2021 Aug; 45(4):1783-1791. PubMed ID: 33619611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosis.
    Grove GL; Togsverd-Bo K; Schwensen JFB; Andersson NW; Nissen CV; Zachariae C; Haedersdal M
    Lasers Surg Med; 2023 Jan; 55(1):105-115. PubMed ID: 36229952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis.
    Lynch OE; Aherne T; Gibbons J; Boland MR; Ryan ÉJ; Boyle E; Egan B; Tierney S
    Ir J Med Sci; 2020 Aug; 189(3):1023-1026. PubMed ID: 31898163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact.
    Lowe N; Naumann M; Eadie N
    Medicine (Baltimore); 2023 Jul; 102(S1):e32764. PubMed ID: 37499084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
    Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
    Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
    Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM
    Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperhidrosis: Implications on symptoms, daily life, health and alcohol consumption when treated with botulinum toxin.
    Shayesteh A; Boman J; Janlert U; Brulin C; Nylander E
    J Dermatol; 2016 Aug; 43(8):928-33. PubMed ID: 26875781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
    Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A.
    Kouris A; Armyra K; Christodoulou C; Karimali P; Karypidis D; Kontochristopoulos G
    ISRN Dermatol; 2014; 2014():308650. PubMed ID: 24891956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
    D'Epiro S; Macaluso L; Salvi M; Luci C; Mattozzi C; Marzocca F; Salvo V; Scarnò M; Calvieri S; Richetta AG
    Clin Ter; 2014; 165(6):e395-400. PubMed ID: 25524193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
    Pariser DM; Hebert AA; Drew J; Quiring J; Gopalan R; Glaser DA
    Am J Clin Dermatol; 2019 Feb; 20(1):135-145. PubMed ID: 30378087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of Efficacy and Safety of Botulinum Toxin a Injections and Subcutaneous Curettage in the Treatment of Axillary Hyperhidrosis.
    Budamakuntla L; Loganathan E; George A; Revanth BN; Sankeerth V; Sarvjnamurthy SA
    J Cutan Aesthet Surg; 2017; 10(1):33-39. PubMed ID: 28529419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.
    Swartling C; Naver H; Lindberg M
    Eur J Neurol; 2001 May; 8(3):247-52. PubMed ID: 11328333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.